DefenceDX
Cardiovascular Disease Risk Assessment (via inflammation detection)
Pre-clinicalActive
Key Facts
Indication
Cardiovascular Disease Risk Assessment (via inflammation detection)
Phase
Pre-clinical
Status
Active
Company
About Alpspitz Bioscience
Alpspitz Bioscience is an early-stage diagnostics company targeting the massive global burden of cardiovascular diseases (CVDs). Its core innovation is the DefenceDX platform, a saliva test that uses AI to analyze inflammatory biomarkers, aiming to provide an easy-to-use, preventative screening tool for CVD risk. The company positions itself in the digital health and preventative diagnostics space, seeking partnerships to advance and commercialize its technology.
View full company profile